Deferitazole

Transfusional Iron Overload

ShireSmall moleculePhase 2Dormant

59/ 100

Provisional rating · Methodology v0.2

Rating breakdown

0 Active assets in the Transfusional Iron Overload cohort.

Asset / Sponsor	Phase	Rating
Deferasirox Novartis Pharmaceuticals	Phase 4	A
Deferiprone Ain Shams University	Phase 3	BB
Deferasirox Novartis Pharmaceuticals	Phase 2	B
DESFERRIOXAMINE B Novartis Pharmaceuticals	Phase 2	B
DESFERRIOXAMINE B Ain Shams University	Phase 2	B
Defearisox Film-Coated Novartis Pharmaceuticals	Phase 2	B
Ferriprox Ain Shams University	N/A	D
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one Horus University		D